Search
image1
HomeProductsCompanyInvestorsNewsSupportContactblog
CellaVision AB - Interim report for the period January 1 - September 30, 2009
2009-10-23
English
Successful launch of CellaVision® DM1200 and a solid earnings trend
  •    Net sales increased by 12% to SEK 69.6 million (62.1), of which the third quarter accounted for SEK 27.0 million (20.8).
  •    The operating profit for the period was SEK 7.3 million (6.3), and for the third quarter SEK 5.5 million (3.6).
  •    Earnings per share for the period amounted to SEK 0.28 (0.25), and for the third quarter SEK 0.22 (0.14).
  •    Cash and cash equivalents amounted to SEK 11.9 million (11.3) by the end of the period.
  •    The new analyzer CellaVision® DM1200 became commercially available in Europe and Canada and was successfully introduced on the market. The first substantial order was taken in Europe.
  •  
     
     
     
    CEO's comment
    "Our new product CellaVision DM1200 is now commercially available in both Europe and Canada which will be beneficial for sales," says Yvonne Mårtensson, CEO of CellaVision. "We got the first substantial order from our distributor Sysmex Europe. The order comprised close to twenty analyzers, which indicates that adapting our product to the needs of medium-sized hospitals was strategically correct."
     
    "We show solid increase in terms of both revenue and results during the third quarter despite the global financial crisis, and we continue to show a strong gross margin."
     
    "During the quarter our own sales organizations have taken orders from important customers in the USA, Canada, Japan, as well as the Nordic region, and we continue to work hard to strengthen our position in each of those markets."
     
    Yvonne Mårtensson
    CEO CellaVision AB
     
     
    For further information, please contact:   
    Yvonne Mårtensson, CEO. Phone: +46 708 33 77 82, e-mail: yvonne.martensson@cellavision.com
    Johan Wennerholm, CFO. Phone: +46 708 33 81 68, e-mail: johan.wennerholm@cellavision.com

    CellaVision AB - Interim report for the period January 1 - Sep 30, 2009
    Archive

    2014
    2013
    2012
    2011
    2010
    2009
    2008
    2007
    2006
    2005
    2004
    2002